Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Lachman Practice Groups

    Three Practices
    Executing One Vision

    Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

    Lachman OnCall Logo

    Get the answers and guidance to your most pressing questions faster than ever before.

    Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

    Learn More About Lachman OnCall

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Halfway Through June 2021, Approval Actions Appear to Hit Sub-Par Numbers

    We have reached the halfway mark of June and, as of the unofficial rep...
    Read More

    CGT Product Approvals Add Ten (10) Since April 1, 2021

    We last posted on Competitive Generic Therapy (CGT) approvals in the b...
    Read More

    Now that the Unapproved Drug Initiative Is Back on the Horizon, FDA Makes Noise About Unapproved Prescription Thyroid Drugs

    In a recent Consumer Update published on its website, the FDA provides...
    Read More
    Sockeye Salmon Jumping Up Falls

    Between a Rock and a Hard Place – Accelerated Approval for Alzheimer’s Drug Brings Cheers and Jeers!

    Three FDA Advisory Committee members resigned over the FDA’s decisio...
    Read More

    OGD Provides Updates to the April 2021 Statistical Report

    The Office of Generic Drugs (OGD) filled in the blanks on its April Ge...
    Read More

    Preliminary Unofficial OGD Approval Numbers for May 2021

    Well, it was May gray, as reported in our previous post (here),as OGD ...
    Read More
    Contact Us Today